Afsharian Parvaneh, Terelius Ylva, Hassan Zuzana, Nilsson Christina, Lundgren Stefan, Hassan Moustapha
Experimental Cancer Medicine, Clinical Research Center, Karolinska University Hospital, Huddinge, Sweden.
Clin Cancer Res. 2007 Jul 15;13(14):4218-24. doi: 10.1158/1078-0432.CCR-07-0320.
The prodrug cyclophosphamide (CPA) is activated by cytochrome P450 (CYP) enzymes. CPA is one of the corner stones in all cancer treatment. We have studied the effect of repeated doses of CPA given at different time intervals on the mRNA, protein levels, and enzyme activity of CYPs in rats.
Two groups of animals (A-75 and A-150) were treated with four doses of CPA (75 and 150 mg/kg, respectively) at short time intervals (6 h). The third group of animals (B-150) was treated with 150 mg/kg at 24-h intervals. Three animals were killed 30 min after administration, and three animals immediately before the next dose.
CYP2B1 and CYP2B2 mRNAs were significantly induced at 6 h after each dose in group A-75 (maximum of 2100-fold and 60-fold after the third dose, respectively), whereas the mRNA levels measured at 6 h postadministration in group A-150 were 1,490-fold and 36-fold after the second dose. In group B-150, no significant induction of mRNA levels was observed. CYP2B1 and CYP2B2 protein levels also increased with increased mRNAs. Plasma levels of 4-hydroxy-CPA measured at 30 min after dose correlated well with the increase in protein levels.
Up-regulation of CYP2B mRNA, with a concomitant increase in protein expression and activity, were observed after repeated administration of low doses of CPA compared with that found using higher doses, possibly due to toxicity counteracting induction. These results may help in designing more effective dosing schedules for CPA.
前体药物环磷酰胺(CPA)由细胞色素P450(CYP)酶激活。CPA是所有癌症治疗的基石之一。我们研究了在不同时间间隔重复给予CPA对大鼠CYP的mRNA、蛋白质水平和酶活性的影响。
两组动物(A - 75和A - 150)在短时间间隔(6小时)内接受四剂CPA(分别为75和150 mg/kg)治疗。第三组动物(B - 150)以24小时间隔接受150 mg/kg治疗。给药后30分钟处死三只动物,在下一次给药前立即处死三只动物。
在A - 75组中,每次给药后6小时CYP2B1和CYP2B2 mRNA均显著诱导(第三剂后分别最高达2100倍和60倍),而A - 150组给药后6小时测得的mRNA水平在第二剂后为1490倍和36倍。在B - 150组中,未观察到mRNA水平的显著诱导。CYP2B1和CYP2B2蛋白质水平也随mRNA增加而升高。给药后30分钟测得的4 - 羟基 - CPA血浆水平与蛋白质水平的增加密切相关。
与高剂量相比,低剂量CPA重复给药后观察到CYP2B mRNA上调,同时蛋白质表达和活性增加,这可能是由于毒性抵消了诱导作用。这些结果可能有助于设计更有效的CPA给药方案。